US OptionsDetailed Quotes
EXAS240719C47500
- 1.00
- +0.45+81.82%
15min DelayClose Jul 10 16:00 ET
1.00High0.75Low
0.75Open0.55Pre Close44 Volume819 Open Interest47.50Strike Price3.71KTurnover58.46%IV6.99%PremiumJul 19, 2024Expiry Date0.00Intrinsic Value100Multiplier9DDays to Expiry1.00Extrinsic Value100Contract SizeAmericanOptions Type0.3301Delta0.0855Gamma51.81Leverage Ratio-0.0860Theta0.0036Rho17.10Eff Leverage0.0262Vega
Exact Sciences Stock Discussion
Sign in to post a comment
$Exact Sciences(EXAS.US$ guys relax sooner or later this will grow just not so soon
1
1
$Exact Sciences(EXAS.US$ whats happening? why it keeps dropping?
$Exact Sciences(EXAS.US$ Good opportunity to buy after correction, "not today" I shall buy in next week once volatility minimized. Good AI stoks but you can see good return not before 2025. I am bullish on it and it will remain my best pick for next 3-5 years invetment tenure.
2
Exact Sciences' progress has failed to meet high market expectations, yet its consistent revenue growth suggests it may be worth further investigation. The company's performance has underperformed the broader market, which gained around 31%.
2
The company's strained balance sheet and lack of EBIT level profitability heighten risk. Its debt management and growth rate are key concerns, with faster growth expected from unprofitable firms.
Exact Sciences' low P/S ratio is due to its poor revenue outlook. Investors foresee limited growth, thus are only willing to pay less for the stock, making a strong share price rise unlikely.
Exact Sciences' growth rate is somewhat slow, showing a 20% rise in revenue while lacking profitability at an EBIT level. Considerable liabilities and negative EBIT results make its financial status seem precarious and risky.
Impressive annual returns suggest the company's improved performance. Its focus on revenue growth proves strategic, although further profitability analysis is wise given the substantial share appreciation.
Gapping up
$Coinbase(COIN.US$+2.38% (The crypto exchange stock climbed in premarket trading, seemingly aided by the surge in bitcoin's 7.8% climb. Coinbase has faced a multiple headwinds recently, from an ongoing spat with the U.S. Securities and Exchange Commission to BlackRock's launch of its own bitcoin exchange-traded fund.)
$MicroStrategy(MSTR.US$+2.58% (Shares have climbed more than 121% so far in 2023 and 8.7% over the past...
$Coinbase(COIN.US$+2.38% (The crypto exchange stock climbed in premarket trading, seemingly aided by the surge in bitcoin's 7.8% climb. Coinbase has faced a multiple headwinds recently, from an ongoing spat with the U.S. Securities and Exchange Commission to BlackRock's launch of its own bitcoin exchange-traded fund.)
$MicroStrategy(MSTR.US$+2.58% (Shares have climbed more than 121% so far in 2023 and 8.7% over the past...
18
No comment yet
Baboompiak : yup holding onto 100 shares at 57.5